Skip to content

Novel approach in rhinoplasty

Comparing clinical findings of rhinoplasty using a novel combination method of osteotome and reciprocal saw with conventional method of osteotomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170316033094N2
Enrollment
60
Registered
2020-07-29
Start date
2020-07-22
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty. Other and unspecified disorders of nose and nasal sinuses

Interventions

Intervention 1: Intervention group: This method performed using two instruments together for rhinoplasty including chisel osteotome and reciprocal saw. During the surgery the time of breaking the nasa

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with any kind of nasal deformity No anesthesia contraindication (American Society of Anesthesiologists physical status I and II) No serious airway malformation (septal deviation, breathing dysfunction). Men and women between the ages of 14 and 50 require surgery for rhinoplasty

Exclusion criteria

Exclusion criteria: Pregnant women Taking antidepressant medications Refusal to participate

Design outcomes

Primary

MeasureTime frame
Edema. Timepoint: The second and seventh day after surgery. Method of measurement: Grade 1: The upper and lower eyelids do not interfere with the pupil.Grade 2: A brief coverage of the pupils with some inflation in the eyelids.Grade 3: Complete coverage of the pupil with significant swelling in the eyelids.Grade 4: Complete Eye Closure.;Pain. Timepoint: First, second and third after surgery. Method of measurement: VAS scale.;Ecchymosis. Timepoint: Day two and seven after surgery. Method of measurement: The KARA method is used to assess ecchymosis. In this way, the results are categorized as follows: Grade 1: Kimos to 3/1 lower or upper eyelid, or both. Grade 2: Echimoses up to 2/2 lower or upper eyelid or both. Grade 3: Eclipse of the entire lower or upper eyelid, or both.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Heidarizade

Arak University of Medical Sciences

drmehdiheidarizadehomfs@gmail.com+98 86 3313 6055

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026